University of Washington Fred Hutch Cancer Center — Seattle, Washington

University of Washington Fred Hutch Cancer Center is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Washington Fred Hutch Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma.

Sponsors: Corvus Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Washington Fred Hutch Cancer Center?

University of Washington Fred Hutch Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Washington Fred Hutch Cancer Center conducted?

University of Washington Fred Hutch Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma.

Is University of Washington Fred Hutch Cancer Center accredited by Crixeo Health?

University of Washington Fred Hutch Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Washington Fred Hutch Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.